Beyond Medical Technologies Stock Z Score
DOCKF Stock | USD 0.07 0.00 0.00% |
Beyond | Z Score |
Beyond Medical Technologies Company Z Score Analysis
Beyond Medical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Beyond Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Beyond Medical is extremely important. It helps to project a fair market value of Beyond Stock properly, considering its historical fundamentals such as Z Score. Since Beyond Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Beyond Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Beyond Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
According to the company's disclosures, Beyond Medical Technologies has a Z Score of 0.0. This is 100.0% lower than that of the Machinery sector and 100.0% lower than that of the Industrials industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
Beyond Fundamentals
Return On Equity | -1.89 | ||||
Return On Asset | -3.8 | ||||
Current Valuation | 1.12 M | ||||
Shares Outstanding | 15.81 M | ||||
Shares Owned By Insiders | 28.57 % | ||||
Price To Earning | 38.84 X | ||||
Price To Book | 17.94 X | ||||
Price To Sales | 1.41 X | ||||
Gross Profit | (250.49 K) | ||||
EBITDA | (773.19 K) | ||||
Net Income | (595.96 K) | ||||
Cash And Equivalents | 877.31 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 30 K | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 3.73 X | ||||
Book Value Per Share | (0.07) X | ||||
Cash Flow From Operations | (527.04 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 27.98 | ||||
Beta | 6128.38 | ||||
Market Capitalization | 1.11 M | ||||
Total Asset | 95.64 K | ||||
Retained Earnings | (26.1 M) | ||||
Working Capital | (334.72 K) | ||||
Net Asset | 95.64 K |
About Beyond Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out Beyond Medical Piotroski F Score and Beyond Medical Valuation analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.